Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2658)	9/27/2001 9:11:47 AM
From: scaram(o)uche	Read Replies (1) of 4974

Another sector milestone.......... Wednesday September 26, 6:31 pm Eastern Time Press Release SOURCE: Visible Genetics Inc. FDA Grants Market Clearance of Visible Genetics' HIV Genotyping System TRUGENE(TM) HIV-1 Genotyping Kit is First FDA Cleared DNA Sequence-Based Test For HIV Drug Resistance Testing TORONTO, Sept. 26 /PRNewswire/ -- Visible Genetics Inc. (Nasdaq: VGIN - news; VGI) today received clearance from the U.S. Food and Drug Administration (FDA) to market its TRUGENE(TM) HIV-1 Genotyping Kit and OpenGene(TM) DNA Sequencing System for routine clinical use, becoming the first HIV drug resistance test to receive clearance from the FDA.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next